PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Syprol 10mg/5ml oral solution
0204000R0BVABCX
Syprol Propranolol hydrochloride Cardiovascular System No data available
Syprol 40mg/5ml oral solution
0204000R0BVADDB
Syprol Propranolol hydrochloride Cardiovascular System No data available
Syprol 50mg/5ml oral solution
0204000R0BVACCY
Syprol Propranolol hydrochloride Cardiovascular System No data available
Syprol 5mg/5ml oral solution
0204000R0BVAACW
Syprol Propranolol hydrochloride Cardiovascular System No data available
Syrup
091101000AABQBQ
Generic compound preparation BNF 0911010 Other amino acidandnutritional agent preparations Nutrition and Blood No data available
Syrup unpreserved
091101000AACDCD
Generic compound preparation BNF 0911010 Other amino acidandnutritional agent preparations Nutrition and Blood No data available
Syscor MR 10 tablets
0206020W0BBAAAA
Syscor Nisoldipine Cardiovascular System No data available
Syscor MR 20 tablets
0206020W0BBABAB
Syscor Nisoldipine Cardiovascular System No data available
Syscor MR 30 tablets
0206020W0BBACAC
Syscor Nisoldipine Cardiovascular System No data available
System 4 multi-layer compression bandage kit 18cm-25cm ankle circumference
20020201050
System 4 multi-layer compression bandage kit 18cm-25cm ankle circumference Arm Sling/Bandages Dressings No data available
System 4 multi-layer compression bandage kit 18cm-25cm ankle circumference (4 components)
20020201051
System 4 multi-layer compression bandage kit 18cm-25cm ankle circumference (4 components) Arm Sling/Bandages Dressings No data available
Tabphyn MR 400microgram capsules (Kyowa Kirin)
0704010U0BFAAAA
Tabphyn Tamsulosin hydrochloride Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Tacni 0.5mg capsules
0802020T0BGAAAF
Tacni Tacrolimus Malignant Disease and Immunosuppression No data available
Tacni 1mg capsules
0802020T0BGABAB
Tacni Tacrolimus Malignant Disease and Immunosuppression No data available
Tacni 5mg capsules
0802020T0BGACAA
Tacni Tacrolimus Malignant Disease and Immunosuppression No data available
Tacrolimus 0.0001% mouthwash
0802020T0AAAXAX
Tacrolimus (Systemic) Tacrolimus Malignant Disease and Immunosuppression No data available
Tacrolimus 25mg/5ml oral liquid
0802020T0AAASAS
Tacrolimus (Systemic) Tacrolimus Malignant Disease and Immunosuppression No data available
Tacrolimus 2mg suppositories
0802020T0AABIBI
Tacrolimus (Systemic) Tacrolimus Malignant Disease and Immunosuppression No data available
Tacrolimus 2mg/5ml oral suspension
0802020T0AAAKAK
Tacrolimus (Systemic) Tacrolimus Malignant Disease and Immunosuppression No data available
Tacrolimus 500micrograms/5ml oral suspension
0802020T0AAARAR
Tacrolimus (Systemic) Tacrolimus Malignant Disease and Immunosuppression No data available
Tacrolimus 5mg/1ml solution for infusion ampoules
0802020T0AAACAC
Tacrolimus (Systemic) Tacrolimus Malignant Disease and Immunosuppression No data available
Tacrolimus 750microgram modified-release tablets
0802020T0AABDBD
Tacrolimus (Systemic) Tacrolimus Malignant Disease and Immunosuppression No data available
Tacrolimus 800micrograms/5ml oral solution
0802020T0AABABA
Tacrolimus (Systemic) Tacrolimus Malignant Disease and Immunosuppression No data available
Tacrolimus 900micrograms/5ml oral suspension
0802020T0AABBBB
Tacrolimus (Systemic) Tacrolimus Malignant Disease and Immunosuppression No data available
Tadomon 250mg prolonged-release tablets
0407020AGBDAEAG
Tadomon Tapentadol Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.